BeOne Medicines
ONC
#652
Rank
C$49.44 B
Marketcap
C$446.83
Share price
-2.56%
Change (1 day)
53.60%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

BeOne Medicines (ONC) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$4.84 Billion

According to BeOne Medicines's latest financial reports the company's total liabilities are C$4.84 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BeOne Medicines - Total liabilities on balance sheet (from 2014 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$3.71 B23.49%
2023-12-31C$3.00 B11.07%
2022-12-31C$2.70 B-11.56%
2021-12-31C$3.06 B38.71%
2020-12-31C$2.20 B166.66%
2019-12-31C$0.82 B22.53%
2018-12-31C$0.67 B48.36%
2017-12-31C$0.45 B540.58%
2016-12-31C$71.09 M20.75%
2015-12-31C$58.87 M82.16%
2014-12-31C$32.32 M-39.9%
2013-12-31C$53.78 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Onconova Therapeutics
ONTX
C$16.82 M-99.65%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
C$0.95 B-80.30%๐Ÿ‡บ๐Ÿ‡ธ USA